CGL
CL icon

Clarius Group LLC’s Colgate-Palmolive CL Stock Holding History

Clarius Group LLC’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$471K Buy
5,965
+3,024
+103% +$237K 0.03% 209
2025
Q3 		$235K Sell
2,941
-800
-21% -$68.2K 0.01% 351
2025
Q2 		$340K Sell
3,741
-542
-13% -$49.5K 0.02% 327
2025
Q1 		$401K Sell
4,283
-93
-2% -$8.33K 0.03% 284
2024
Q4 		$398K Sell
4,376
-70
-2% -$6.68K 0.03% 261
2024
Q3 		$459K Sell
4,446
-63
-1% -$6.42K 0.03% 231
2024
Q2 		$438K Sell
4,509
-236
-5% -$21.8K 0.03% 236
2024
Q1 		$427K Sell
4,745
-752
-14% -$63.7K 0.03% 257
2023
Q4 		$438K Buy
5,497
+407
+8% +$30.6K 0.04% 258
2023
Q3 		$362K Sell
5,090
-1,929
-27% -$144K 0.03% 282
2023
Q2 		$541K Sell
7,019
-108
-2% -$8.36K 0.04% 241
2023
Q1 		$536K Sell
7,127
-35
-0.5% -$2.6K 0.05% 238
2022
Q4 		$564K Sell
7,162
-621
-8% -$46.6K 0.05% 223
2022
Q3 		$547K Sell
7,783
-254
-3% -$19.9K 0.05% 203
2022
Q2 		$644K Buy
8,037
+122
+2% +$9.54K 0.06% 184
2022
Q1 		$675K Hold
7,915
– – 0.05% 186
2021
Q4 		$675K Buy
7,915
+399
+5% +$31.2K 0.05% 186
2021
Q3 		$568K Buy
7,516
+119
+2% +$9.45K 0.05% 191
2021
Q2 		$602K Buy
7,397
+167
+2% +$13.7K 0.05% 179
2021
Q1 		$570K Sell
7,230
-1,201
-14% -$94.1K 0.06% 169
2020
Q4 		$721K Buy
8,431
+2,301
+38% +$190K 0.08% 126
2020
Q3 		$473K Sell
6,130
-608
-9% -$46.4K 0.06% 144
2020
Q2 		$494K Buy
6,738
+776
+13% +$55.1K 0.07% 138
2020
Q1 		$396K Sell
5,962
-330
-5% -$23.3K 0.07% 135
2019
Q4 		$445K Sell
6,292
-93
-1% -$6.34K 0.07% 145
2019
Q3 		$469K Buy
6,385
+648
+11% +$47K 0.09% 126
2019
Q2 		$411K Buy
5,737
+1,279
+29% +$90.8K 0.08% 125
2019
Q1 		$306K Buy
+4,458
New +$288K 0.07% 138

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clarius Group LLC's CL Position: Q4 2025 in Review

Clarius Group LLC increased its Colgate-Palmolive (CL) stake by 103% in Q4 2025, buying an estimated $237K and bringing the position to 5,965 shares worth $471K. The position accounts for 0.03% of the portfolio, ranked #209.

Clarius Group LLC first reported a position in CL in Q1 2019 and has held it in 28 quarters since. The position peaked at $721K in Q4 2020. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Clarius Group LLC held 5,965 shares of Colgate-Palmolive worth $471K as of Q4 2025.
  • Clarius Group LLC bought 3,024 Colgate-Palmolive shares in Q4 2025, an estimated $237K.
  • Colgate-Palmolive made up 0.03% of Clarius Group LLC's portfolio in Q4 2025, its #209 holding.
  • Clarius Group LLC first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 28 quarters since.
  • Clarius Group LLC's Colgate-Palmolive position peaked at $721K in Q4 2020.
  • 1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.